nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—cardial valve—chronic kidney failure	0.144	0.564	CbGeAlD
Sulfisoxazole—CYP2C9—urine—chronic kidney failure	0.031	0.122	CbGeAlD
Sulfisoxazole—EDNRA—urethra—chronic kidney failure	0.0225	0.0884	CbGeAlD
Sulfisoxazole—EDNRA—cortex of kidney—chronic kidney failure	0.0216	0.0848	CbGeAlD
Sulfisoxazole—CYP2C9—blood plasma—chronic kidney failure	0.0162	0.0635	CbGeAlD
Sulfisoxazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C19—chronic kidney failure	0.0145	0.0208	CbGpPWpGaD
Sulfisoxazole—CYP2C9—CYP2E1 reactions—CYP2C19—chronic kidney failure	0.0123	0.0177	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2B6—chronic kidney failure	0.0106	0.0153	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic kidney failure	0.00937	0.0135	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2C18—chronic kidney failure	0.00922	0.0132	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—NOS3—chronic kidney failure	0.00911	0.0131	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—chronic kidney failure	0.00899	0.0129	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—EDN1—chronic kidney failure	0.00892	0.0128	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic kidney failure	0.00853	0.0122	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.0083	0.0119	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2C19—chronic kidney failure	0.00764	0.011	CbGpPWpGaD
Sulfisoxazole—CYP2C9—cardiovascular system—chronic kidney failure	0.0075	0.0294	CbGeAlD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP2C19—chronic kidney failure	0.00734	0.0105	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—chronic kidney failure	0.0073	0.0105	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—NAT8—chronic kidney failure	0.00711	0.0102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—CCR5—chronic kidney failure	0.00701	0.0101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.00695	0.00998	CbGpPWpGaD
Sulfisoxazole—Sulfaphenazole—CYP2B6—chronic kidney failure	0.00663	0.136	CrCbGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC3—chronic kidney failure	0.0066	0.00948	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—chronic kidney failure	0.00633	0.00909	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.00629	0.00903	CbGpPWpGaD
Sulfisoxazole—CYP2C9—digestive system—chronic kidney failure	0.00622	0.0244	CbGeAlD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP3A4—chronic kidney failure	0.00604	0.00867	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.00603	0.00866	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—CCR5—chronic kidney failure	0.00594	0.00853	CbGpPWpGaD
Sulfisoxazole—CYP2C9—blood—chronic kidney failure	0.00593	0.0233	CbGeAlD
Sulfisoxazole—Dapsone—CYP2C18—chronic kidney failure	0.00592	0.121	CrCbGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—NPY—chronic kidney failure	0.00586	0.00842	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP3A4—chronic kidney failure	0.00581	0.00834	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—OXT—chronic kidney failure	0.00573	0.00822	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—OXT—chronic kidney failure	0.00565	0.00812	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—NPS—chronic kidney failure	0.00543	0.0078	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—NPS—chronic kidney failure	0.00536	0.0077	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2C19—chronic kidney failure	0.00524	0.00753	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—chronic kidney failure	0.00512	0.00736	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—chronic kidney failure	0.00486	0.00697	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP1A1—chronic kidney failure	0.0045	0.00646	CbGpPWpGaD
Sulfisoxazole—Sulfamethazine—ALB—chronic kidney failure	0.00442	0.0904	CrCbGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—chronic kidney failure	0.00441	0.00634	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—chronic kidney failure	0.00436	0.00626	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic kidney failure	0.00433	0.00622	CbGpPWpGaD
Sulfisoxazole—Sulfamerazine—ALB—chronic kidney failure	0.00432	0.0884	CrCbGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—chronic kidney failure	0.00415	0.00596	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—DRD1—chronic kidney failure	0.00412	0.00591	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—chronic kidney failure	0.00405	0.00581	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.00395	0.00567	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPY—chronic kidney failure	0.00393	0.00565	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—AVP—chronic kidney failure	0.00393	0.00564	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.00388	0.00558	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—AVP—chronic kidney failure	0.00388	0.00557	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—chronic kidney failure	0.00383	0.0055	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—OXT—chronic kidney failure	0.00379	0.00545	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—chronic kidney failure	0.00378	0.00542	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CRHR1—chronic kidney failure	0.00377	0.00541	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—EDN1—chronic kidney failure	0.00373	0.00536	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—PTGS1—chronic kidney failure	0.00369	0.0755	CrCbGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—EDN1—chronic kidney failure	0.00369	0.00529	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.00367	0.00527	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCL5—chronic kidney failure	0.00366	0.00525	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—chronic kidney failure	0.0036	0.00516	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.00358	0.00514	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD1—chronic kidney failure	0.00353	0.00506	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—chronic kidney failure	0.00351	0.00504	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—PTH—chronic kidney failure	0.00345	0.00495	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—chronic kidney failure	0.00336	0.00482	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.00336	0.00482	CbGpPWpGaD
Sulfisoxazole—Sulfamethizole—ALB—chronic kidney failure	0.00335	0.0685	CrCbGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic kidney failure	0.00334	0.0048	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCR5—chronic kidney failure	0.0033	0.00473	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.0032	0.00459	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.00317	0.00455	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.00313	0.00449	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.0031	0.00446	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPY—chronic kidney failure	0.00299	0.0043	CbGpPWpGaD
Sulfisoxazole—Sulfanilamide—CYP2C19—chronic kidney failure	0.00297	0.0608	CrCbGaD
Sulfisoxazole—Dapsone—PTGS1—chronic kidney failure	0.00289	0.0591	CrCbGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—OXT—chronic kidney failure	0.00289	0.00415	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CRH—chronic kidney failure	0.00289	0.00415	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—F2—chronic kidney failure	0.00286	0.00411	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—F2—chronic kidney failure	0.00283	0.00406	CbGpPWpGaD
Sulfisoxazole—Sulfadiazine—CYP3A4—chronic kidney failure	0.00278	0.0569	CrCbGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPS—chronic kidney failure	0.00274	0.00393	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.00269	0.00387	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—DRD1—chronic kidney failure	0.00269	0.00386	CbGpPWpGaD
Sulfisoxazole—Dapsone—CYP2C19—chronic kidney failure	0.00265	0.0543	CrCbGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.0026	0.00373	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.00258	0.00371	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—POMC—chronic kidney failure	0.00258	0.0037	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.00257	0.00369	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—F2—chronic kidney failure	0.00256	0.00368	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCL2—chronic kidney failure	0.00252	0.00362	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—chronic kidney failure	0.00251	0.0036	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—chronic kidney failure	0.00248	0.00355	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.00247	0.00355	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.00245	0.00352	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.00235	0.00338	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.00221	0.00317	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	0.00216	0.00311	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—CYP3A4—chronic kidney failure	0.00216	0.0441	CrCbGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CRHR1—chronic kidney failure	0.00213	0.00306	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	0.00203	0.00292	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AVP—chronic kidney failure	0.00198	0.00284	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PTH—chronic kidney failure	0.00195	0.0028	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CRHR1—chronic kidney failure	0.00193	0.00278	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2B6—chronic kidney failure	0.0019	0.00273	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.0019	0.00272	CbGpPWpGaD
Sulfisoxazole—Sulfanilamide—CYP3A4—chronic kidney failure	0.00189	0.0387	CrCbGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—EDN1—chronic kidney failure	0.00188	0.0027	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—ALB—chronic kidney failure	0.00188	0.0385	CrCbGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.00187	0.00269	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.00187	0.00268	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL5—chronic kidney failure	0.00187	0.00268	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.00184	0.00265	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PTH—chronic kidney failure	0.00177	0.00254	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.00173	0.00248	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPY—chronic kidney failure	0.00169	0.00243	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00169	0.00243	CbGpPWpGaD
Sulfisoxazole—Dapsone—CYP3A4—chronic kidney failure	0.00169	0.0345	CrCbGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCR5—chronic kidney failure	0.00168	0.00242	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—chronic kidney failure	0.00165	0.0338	CrCbGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2C18—chronic kidney failure	0.00165	0.00237	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OXT—chronic kidney failure	0.00163	0.00234	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CRH—chronic kidney failure	0.00163	0.00234	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.00163	0.00233	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—COL4A5—chronic kidney failure	0.00162	0.00233	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPS—chronic kidney failure	0.00155	0.00222	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPY—chronic kidney failure	0.00154	0.00221	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DRD1—chronic kidney failure	0.00152	0.00218	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.00152	0.00218	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TFDP2—chronic kidney failure	0.00151	0.00216	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OXT—chronic kidney failure	0.00148	0.00213	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CRH—chronic kidney failure	0.00148	0.00213	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00148	0.00212	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—F2—chronic kidney failure	0.00144	0.00207	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPS—chronic kidney failure	0.00141	0.00202	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.00139	0.002	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DRD1—chronic kidney failure	0.00138	0.00198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2C19—chronic kidney failure	0.00137	0.00196	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.00135	0.00193	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PGF—chronic kidney failure	0.00134	0.00193	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—POMC—chronic kidney failure	0.00132	0.00189	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL2—chronic kidney failure	0.00129	0.00185	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—chronic kidney failure	0.00129	0.00185	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.00127	0.00182	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKAG2—chronic kidney failure	0.00126	0.00181	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—PTGS1—chronic kidney failure	0.00125	0.00179	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	0.00125	0.00179	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—COL4A3—chronic kidney failure	0.0012	0.00172	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HBEGF—chronic kidney failure	0.00117	0.00168	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CRHR1—chronic kidney failure	0.00114	0.00164	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.00113	0.00162	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AVP—chronic kidney failure	0.00112	0.00161	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.0011	0.00158	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LRP2—chronic kidney failure	0.0011	0.00157	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP3A4—chronic kidney failure	0.00108	0.00155	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP3A4—chronic kidney failure	0.00107	0.00153	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—EDN1—chronic kidney failure	0.00106	0.00153	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCL5—chronic kidney failure	0.00106	0.00152	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTH—chronic kidney failure	0.00104	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CYBB—chronic kidney failure	0.00102	0.00146	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AVP—chronic kidney failure	0.00102	0.00146	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	0.00101	0.00146	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EDN1—chronic kidney failure	0.000966	0.00139	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF23—chronic kidney failure	0.000964	0.00138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL5—chronic kidney failure	0.000959	0.00138	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR5—chronic kidney failure	0.000951	0.00137	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPY—chronic kidney failure	0.000908	0.0013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OXT—chronic kidney failure	0.000876	0.00126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CRH—chronic kidney failure	0.000876	0.00126	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.000871	0.00125	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR5—chronic kidney failure	0.000864	0.00124	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000852	0.00122	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NCF1—chronic kidney failure	0.000839	0.0012	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPS—chronic kidney failure	0.00083	0.00119	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.000819	0.00118	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—F2—chronic kidney failure	0.000816	0.00117	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRD1—chronic kidney failure	0.000814	0.00117	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1A1—chronic kidney failure	0.000805	0.00116	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic kidney failure	0.000794	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CYBA—chronic kidney failure	0.000788	0.00113	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—POMC—chronic kidney failure	0.000743	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—F2—chronic kidney failure	0.000741	0.00106	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	0.00073	0.00105	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	0.00073	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HBEGF—chronic kidney failure	0.000692	0.000994	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	0.000683	0.000981	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—POMC—chronic kidney failure	0.000675	0.00097	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL2—chronic kidney failure	0.000661	0.000949	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	0.00066	0.000948	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	0.000646	0.000928	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	0.000633	0.000909	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AVP—chronic kidney failure	0.0006	0.000862	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—POMC—chronic kidney failure	0.0006	0.000862	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDN1—chronic kidney failure	0.000571	0.00082	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL5—chronic kidney failure	0.000566	0.000813	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FABP1—chronic kidney failure	0.000566	0.000813	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LPL—chronic kidney failure	0.000554	0.000795	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	0.000538	0.000773	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GATM—chronic kidney failure	0.000536	0.00077	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AGXT—chronic kidney failure	0.000536	0.00077	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NGF—chronic kidney failure	0.000525	0.000753	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	0.000524	0.000753	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	0.000524	0.000753	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR5—chronic kidney failure	0.00051	0.000733	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACAT1—chronic kidney failure	0.000491	0.000705	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	0.000484	0.000696	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	0.00048	0.000689	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	0.00047	0.000675	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	0.000458	0.000657	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	0.000456	0.000655	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	0.000448	0.000643	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2—chronic kidney failure	0.000438	0.000629	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	0.000417	0.000599	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IRS1—chronic kidney failure	0.000414	0.000595	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	0.000408	0.000586	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—POMC—chronic kidney failure	0.000399	0.000573	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL2—chronic kidney failure	0.00039	0.00056	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCG1—chronic kidney failure	0.000388	0.000557	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—chronic kidney failure	0.000384	0.000551	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	0.00038	0.000545	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ARG2—chronic kidney failure	0.000372	0.000534	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LCAT—chronic kidney failure	0.000365	0.000524	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SERPINE1—chronic kidney failure	0.000364	0.000523	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—chronic kidney failure	0.000361	0.000518	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—chronic kidney failure	0.000348	0.000499	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DDC—chronic kidney failure	0.000335	0.000481	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RELA—chronic kidney failure	0.000327	0.00047	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	0.000325	0.000467	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	0.000325	0.000467	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PRKD1—chronic kidney failure	0.000325	0.000467	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	0.00032	0.00046	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	0.000309	0.000444	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SREBF2—chronic kidney failure	0.000304	0.000437	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCC3—chronic kidney failure	0.000294	0.000422	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GCKR—chronic kidney failure	0.000294	0.000422	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—chronic kidney failure	0.000293	0.000421	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LPIN1—chronic kidney failure	0.000288	0.000413	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	0.000283	0.000406	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LRP2—chronic kidney failure	0.000282	0.000405	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	0.000282	0.000405	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NFKB1—chronic kidney failure	0.000276	0.000396	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—chronic kidney failure	0.000251	0.00036	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CPT1A—chronic kidney failure	0.00024	0.000344	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LIPC—chronic kidney failure	0.000234	0.000335	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	0.000234	0.000335	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	0.00023	0.000331	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—chronic kidney failure	0.00023	0.00033	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SCARB1—chronic kidney failure	0.000216	0.00031	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS1—chronic kidney failure	0.000214	0.000307	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—chronic kidney failure	0.000213	0.000306	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	0.00021	0.000302	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SREBF1—chronic kidney failure	0.000209	0.000301	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMGCR—chronic kidney failure	0.000204	0.000293	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FASN—chronic kidney failure	0.000199	0.000286	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	0.000185	0.000265	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	0.000184	0.000264	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCA1—chronic kidney failure	0.000182	0.000261	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—chronic kidney failure	0.000173	0.000249	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—chronic kidney failure	0.000154	0.000221	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—chronic kidney failure	0.00015	0.000215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LPL—chronic kidney failure	0.000143	0.000205	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	0.000138	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—chronic kidney failure	0.000128	0.000184	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARA—chronic kidney failure	0.000126	0.000181	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—POMC—chronic kidney failure	0.000103	0.000147	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—chronic kidney failure	9.36e-05	0.000134	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—chronic kidney failure	8.95e-05	0.000129	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—chronic kidney failure	8.18e-05	0.000118	CbGpPWpGaD
